The Role of Estrogen in Schizophrenia

Overview

Journal J Psychiatry Neurosci

Specialty Psychiatry

Date 1996 Mar 1

PMID 8820178

Citations 24

Authors

M V Seeman

Affiliations

Soon will be listed here.

Abstract

This paper reviews 3 recent studies from different clinics correlating psychotic symptoms with phases of the menstrual cycle in women with schizophrenia. The aim of the paper is to focus on the estrogen protection hypothesis which would suggest that low estrogen phases correlate with more severe symptoms, and high estrogen phases correlate with less severe symptoms. Although the methodology of the 3 studies was different, the hypothesis was essentially upheld. High levels of estrogens protect against symptom exacerbations in women with schizophrenia. A corollary to this finding is that, for optimal efficacy and safety, neuroleptic doses could be reduced at certain times of the month and increased at others.

Citing Articles

Identifying causal associations between women's reproductive traits and risk of schizophrenia: a multivariate validated two-sample Mendelian randomization analysis.

Sun W, Wu X, Yang H, Yuan S, Chen J, Fang Y BMC Psychiatry. 2024; 24(1):161.

PMID: 38395764 PMC: 10893634. DOI: 10.1186/s12888-024-05614-5.

Estrogen and psychosis - a review and future directions.

Mu E, Gurvich C, Kulkarni J Arch Womens Ment Health. 2024; 27(6):877-885.

PMID: 38221595 PMC: 11579214. DOI: 10.1007/s00737-023-01409-x.

Understanding the Impact of Menopause on Women With Schizophrenia-Spectrum Disorders: A Comprehensive Review.

Tiwari S, Prasad R, Wanjari M, Sharma R Cureus. 2023; 15(4):e37979.

PMID: 37223185 PMC: 10202668. DOI: 10.7759/cureus.37979.

Exploring a Possible Interplay between Schizophrenia, Oxytocin, and Estrogens: A Narrative Review.

Papadea D, Dalla C, Tata D Brain Sci. 2023; 13(3).

PMID: 36979271 PMC: 10046503. DOI: 10.3390/brainsci13030461.

Regulation of sex differences in risk-based decision making by gonadal hormones: Insights from rodent models.

Orsini C, Truckenbrod L, Wheeler A Behav Processes. 2022; 200:104663.

PMID: 35661794 PMC: 9893517. DOI: 10.1016/j.beproc.2022.104663.

References

Goldstein J, Faraone S, Chen W, Tolomiczencko G, Tsuang M . Sex differences in the familial transmission of schizophrenia. Br J Psychiatry. 1990; 156:819-26. DOI: 10.1192/bjp.156.6.819. View

Prudo R, Blum H . Five-year outcome and prognosis in schizophrenia: a report from the London Field Research Centre of the International Pilot Study of Schizophrenia. Br J Psychiatry. 1987; 150:345-54. DOI: 10.1192/bjp.150.3.345. View

Hallonquist J, Seeman M, Lang M, Rector N . Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry. 1993; 33(3):207-9. DOI: 10.1016/0006-3223(93)90141-y. View

Chakos M, Mayerhoff D, Loebel A, Alvir J, Lieberman J . Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia. Psychopharmacol Bull. 1992; 28(1):81-6. View

Shtasel D, Gur R, Gallacher F, Heimberg C, Gur R . Gender differences in the clinical expression of schizophrenia. Schizophr Res. 1992; 7(3):225-31. DOI: 10.1016/0920-9964(92)90016-x. View

Luggin R, Bernsted L, Petersson B, Jacobsen A . Acute psychiatric admission related to the menstrual cycle. Acta Psychiatr Scand. 1984; 69(6):461-5. DOI: 10.1111/j.1600-0447.1984.tb02520.x. View

Bedard P, Langelier P, Villeneuve A . Oestrogens and extrapyramidal system. Lancet. 1977; 2(8052-8053):1367-8. DOI: 10.1016/s0140-6736(77)90429-9. View

Hambrecht M, Maurer K, Hafner H . Evidence for a gender bias in epidemiological studies of schizophrenia. Schizophr Res. 1993; 8(3):223-31. DOI: 10.1016/0920-9964(93)90020-j. View

Riecher-Rossler A, Hafner H . Schizophrenia and oestrogens--is there an association?. Eur Arch Psychiatry Clin Neurosci. 1993; 242(6):323-8. DOI: 10.1007/BF02190244. View

10.

Dworkin R . Patterns of sex differences in negative symptoms and social functioning consistent with separate dimensions of schizophrenic psychopathology. Am J Psychiatry. 1990; 147(3):347-9. DOI: 10.1176/ajp.147.3.347. View

11.

Villeneuve A, Cazejust T, Cote M . Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology. 1980; 6(3):145-51. DOI: 10.1159/000117746. View

12.

Chang S, Renshaw D . Psychosis and pregnancy. Compr Ther. 1986; 12(10):36-41. View

13.

Takei N, OCallaghan E, Sham P, Glover G, Murray R . Does prenatal influenza divert susceptible females from later affective psychosis to schizophrenia?. Acta Psychiatr Scand. 1993; 88(5):328-36. DOI: 10.1111/j.1600-0447.1993.tb03468.x. View

14.

Di Paolo T . Modulation of brain dopamine transmission by sex steroids. Rev Neurosci. 1994; 5(1):27-41. DOI: 10.1515/revneuro.1994.5.1.27. View

15.

Hafner H, Riecher A, Maurer K, Loffler W, Munk-Jorgensen P, STROMGREN E . How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med. 1989; 19(4):903-18. DOI: 10.1017/s0033291700005626. View

16.

Leff J, Sartorius N, Jablensky A, Korten A, Ernberg G . The International Pilot Study of Schizophrenia: five-year follow-up findings. Psychol Med. 1992; 22(1):131-45. DOI: 10.1017/s0033291700032797. View

17.

Goldstein J . Gender differences in the course of schizophrenia. Am J Psychiatry. 1988; 145(6):684-9. DOI: 10.1176/ajp.145.6.684. View

18.

Seeman M, Lang M . The role of estrogens in schizophrenia gender differences. Schizophr Bull. 1990; 16(2):185-94. DOI: 10.1093/schbul/16.2.185. View

19.

McEwen B . Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 1991; 12(4):141-7. DOI: 10.1016/0165-6147(91)90531-v. View

20.

Yassa R, Jeste D . Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull. 1992; 18(4):701-15. DOI: 10.1093/schbul/18.4.701. View